Evidence map›Paper›PMID 36194676›Full record

ArticleOrganic letters2022

New Rufomycins from

Bin Zhou, Gauri Shetye, Nina M Wolf, Shao-Nong Chen, Mallique Qader, G Joseph Ray, David C Lankin, Sanghyun Cho, Jinhua Cheng, Joo-Won Suh and 3 more

Abstract read
In one paragraph

Article in Organic letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. NewTheScientificWorldJournal · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bin ZhouPharmacognosy Institute and Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.ORCID 0000-0001-9000-5320
Gauri ShetyeInstitute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.
Nina M WolfInstitute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.
Shao-Nong ChenPharmacognosy Institute and Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.ORCID 0000-0003-0748-0863
Mallique QaderInstitute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.
G Joseph RayPharmacognosy Institute and Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.
David C LankinPharmacognosy Institute and Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.ORCID 0000-0003-3166-5980
Sanghyun ChoInstitute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.ORCID 0000-0003-0926-6246
Jinhua ChengMyongji Bioefficacy Research Center, Myongji University, 116 Myongji-ro, Yongin, Gyeonggi-do 17058, Republic of Korea.
Joo-Won SuhMyongji Bioefficacy Research Center, Myongji University, 116 Myongji-ro, Yongin, Gyeonggi-do 17058, Republic of Korea.
Scott G FranzblauPharmacognosy Institute and Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.ORCID 0000-0002-8698-0243
James B McAlpinePharmacognosy Institute and Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.ORCID 0000-0003-1696-8828
Guido F PauliPharmacognosy Institute and Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612, United States.ORCID 0000-0003-1022-4326

Funding

UIC: In vitro In vivo Mtb PharmacologyU19AI142735 · NIAID · GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT · PI FOTOUHI, NADER · 2019 to 2023
$28.5M
NIAID NIH HHS U19 AI142735
6 · The paper itself

Abstract

Four new rufomycins, compounds

Indexed as

Antitubercular AgentsMycobacterium tuberculosisOligopeptidesStreptomycesHumansMicrobial Sensitivity TestsPeptides, CyclicStructure-Activity RelationshipAntitubercular AgentsOligopeptidesPeptides, Cyclicrufomycin

Identifiers

PMID36194676
PMCPMC9588618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.